Current and future concepts of abdominal sepsis

World Journal of Surgery

Volumn 29, Issue 1, 2005, Pages 3-9

  Emmanuel, Klaus ^a   Weighardt, Heike ^a   Bartels, Holger ^a   Siewert, Jorg Rudiger ^a   Holzmann, Bernhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT;

ABDOMINAL SURGERY; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ESCHERICHIA COLI; HUMAN; INTENSIVE CARE UNIT; LAPAROTOMY; PERITONITIS; POSTOPERATIVE COMPLICATION; REVIEW; SEPSIS;

CALCITONIN; DRAINAGE; HUMANS; MEMBRANE GLYCOPROTEINS; PERITONITIS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROTEIN PRECURSORS; RECEPTORS, CELL SURFACE; SEPSIS; TOLL-LIKE RECEPTORS;

EID: 4844220771     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7769-6     Document Type: Review

References (93)

1. RA Goris TP te Boekhorst JK Nuytinck 1985 Multiple-organ failure: generalized autodestructive inflammation? Arch Surg. 120 1109 1985
2. JC Marshall D Sweeney 1990 Microbial infection and the septic response in critical illness Arch. Surg. 125 17
3. DH Wittmanm 1990 Symposium of intra-abdominal infections: introduction World J. Surg. 14 145
4. DH Wittmann M Schein RE Condon 1996 Management of secondary peritonitis Ann. Surg. 224 10
5. DH Witmann AP Walker 1993 Peritonitis, intra-abdominal infection, and intra-abdominal abscess SI Schwartz GT Shies FC Spencer Principles of Surgery McGraw-Hill New York 1449 1484
6. OD Rotstein JL Meakinsi 1990 Diagnostic and therapeutic challenges of intraabdominal infections World J. Surg. 14 159
7. OD Rotstein RL Simmonsy 1994 Peritonitis and intraabdominal abscess PS Barie GT Shires Surgical Intensive Care Little Brown Boston 1043 1063
8. PQ Eichacker C Parent A Kalil 2002 Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis Am. J. Respir. Crit. Care Med. 166 1197
9. JC Marshall M Innes 2003 Intensive care unit management of intra-abdominal infection Crit. Care Med. 31 2228
10. RS Hotchkiss IE Karl 2003 The pathophysiology and treatment of sepsis N. Engl. J. Med. 348 138
11. B Lamme MA Boermeestey JB Reitsma 2002 Meta-analysis of relaparotomy for secondary peritonitis Br. J. Surg. 89 1516
12. RR Hutchins MP Gunning DN Lucas 2004 Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery World J. Surg. 28 137
13. AL Adkins J Robbins M Villalba 2004 Open abdomen management of intra-abdominal sepsis Am. Surg. 70 137
14. J Bohnen M Boulanger JL Meakins 1983 Prognosis in generalized peritonitis: relation to cause and risk factors Arch. Surg. 118 285
15. L Meakins JS Solomkin MD Allo 1984 Proposed classification of intra-abdominal infections Arch. Surg. 119 1372
16. EP Dellinger MJ Wertz JL Meakins 1985 Surgical infection stratification system for intra-abdominal infection Arch. Surg. 120 21
17. WA Knaus EA Draper DP Wagner 1985 APACHE II: a severity of disease classification system Crit. Care Med. 13 818
18. PO Nystrom R Bax EP Dellinger 1990 Proposed definitions for diagnosis, severity scoring, stratifications, and outcome for trials on intra-abdominal infection World J. Surg. 14 148
19. K Emmanuilidis H Weighardt E Matevossian 2002 Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: high serum IL-18 as an early predictive indicator of lethal outcome Shock 18 301
20. H Bartels 2002 Akutes Abdomen aus intensivmedizinischer Sicht Chir. Gastroenterol. 18 260
21. H Bartels W Bathlen J Stadler 1995 Therapieaspekte bei septischen Abdominalerkrankungen Chir. Gastroenterol. 11 9
22. W Heagy C Hansen K Niemann 2000 Impaired ex vivo lipopolysaccharide- stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients Shock 14 271
23. M Schein 1992 Management of severe intra-abdominal infection Surg. Ann. 24 47
24. M Schein R Saadia 1988 Intraoperative peritoneal lavage Surg. Gynecol. Obstet. 166 187
25. M Schein G Cecelter W Freinkel 1990 Peritonel lavage in abdominal sepsis: a controlled clinical study Arch. Surg. 125 1132
26. EH Farthmann U Schoffel 1990 Principles and limitations of operative management of intra-abdominal infections World J. Surg. 14 210
27. CD Heidecke T Hensler H Weighardt 1999 Selective defects of T lymphocyte function in patients with lethal intraabdominal infection Am. J. Surg. 178 288
28. M Schein DH Wittmann C Aprahamian 1995 Abdominal compartment syndrome: the physiological and clinical consequences of elevated intra-abdominal pressure J. Am. Coll. Surg. 180 745
29. D Steinberg 1979 On leaving the peritoneal cavity open in acute generalized suppurative peritonitis Am. J. Surg. 137 216
30. M Schein R Saadia GG Decker 1986 The open management of the septic abdomen Surg. Gynecol. Obstet. 163 587
31. KDH Wittmann C Aprahamian JM Bergstein 1990 Etappenlavage, advanced diffuse peritonitis managed by planned multiple laparotomies utilizing zippers, slide fastener, and Velcro analogue for temporary abdominal closure World J. Surg. 14 218
32. R Ivatury M Nallathambi R Prakaschanda 1989 Open management of the septic abdomen: therapeutic and prognostic consideration based on APACHE II Crit. Care Med. 17 511
33. E Levy D Palmer P Frileux 1988 Septic necrosis of the midline wound in postoperative peritonitis Ann. Surg. 207 470
34. DH Wittmann N Bansal JM Bergstein 1994 Staged abdominal repair compares favorably with conventional operative therapy for intra-abdominal infections when adjusting for prognostic factors with a logistic model Theor. Surg. 9 201
35. JL Garcia-Sabrido JM Tellado NW Christou 1988 Treatment of severe intra-abdominal sepsis and/or necrotic foci by an "open abdomen" approach Arch. Surg. 123 152
36. EV Kinney HC Polk 1987 Open treatment of peritonitis: an argument against Adv. Surg. 21 19
37. NV Christou PS Barie EP Dellinger 1993 Surgical Infection Society intra-abdominal infection study: prospective evaluation of management techniques and outcome Arch. Surg. 128 193
38. K Bosscha TJ van Vroonhoven C van der Werken 1999 Surgical management of severe secondary peritonitis Br. J. Surg. 86 1371
39. H Van Goor 1997 Surgical treatment of severe intra-abdominal infection Hepatogastroenterology 44 975
40. S Mulier F Penninckx C Verwaest 2003 Factors affecting mortality in generalized postoperative peritonitis: multivariate analysis in 96 patients World J. Surg. 27 379
41. T Sauter P Gotzinger E-M Redl-Wenzl 1997 Does reoperation for abdominal sepsis enhance the inflammatory host response? Arch. J. Surg. 132 250
42. H Weighardt CD Heidecke A Westerholt 2002 Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis Ann. Surg. 4 560
43. M Majetschak S Flohe U Obertacke 1999 Relation of a TNF gene polymorphism to severe sepsis in trauma patients Ann. Surg. 230 207
44. V Kahlke C Schafmayer B Schniewind 2004 Are postoperative complications genetically determined by TNF-? Ncol gene polymorphism? Surgery 135 365
45. J Riese K Woerner P Zimmermann 2003 Association of a TNFbeta gene polymorphism with complications after major abdominal operations Shock 19 1
46. XM Fang S Schroder A Hoeft 1999 Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis Crit. Care Med. 27 1330
47. F Arnalich E Garcia-Palomero J Lopez 2000 Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis Infect. Immun. 68 1942
48. T Hensler CD Heidecke H Hecker 1998 Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production J. Immunol. 161 2655
49. JP Mira A Cariou F Grall 1999 Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study JAMA 282 561
50. F Stuber M Petersen F Bokelmann 1996 A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis Crit. Care Med. 24 381
51. PJ Guillou 1993 Biological variation in the development of sepsis after surgery or trauma Surgery 342 217
52. E Faist 1996 The mechanisms of host defense dysfunction following shock and trauma ET Rietschel H Wagner Pathology of Septic Shock Springer-Verlag Heidelberg 259 274
53. AC Windsor A Klava SS Somers 1995 Manipulation of local and systemic host defense in the prevention of perioperative sepsis Br. J. Surg. 82 1460
54. T Hensler H Hecker K Heeg 1997 Distinct mechanisms of immunosuppression as a consequence of major surgery Int. Immunol. 65 2283
55. IB Brune W Wilke T Hensler 1999 Down-regulation of Th1 immune response and altered pro- and anti-inflammatory T cell cytokine balance following conventional, but not laparoscopic, surgery Am. J. Surg. 177 55
56. F Carlei M Schietroma G Cianca 1999 Effects of laparoscopic and conventional (open) cholejystectomy on human leukocyte antigen-DR expression peripheral blood monocytes: correlations with immunologic status World J. Surg. 23 18
57. D Decker M Schondorf F Bidlingmaier 1996 Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma Surgery. 119 316
58. MJ Hershman WG Cheadle SR Wellhausen 1990 Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient Br. J. Surg. 77 204
59. S Akira 2000 The role of IL-18 in innate immunity Curr. Opin. Immunol. 12 59
60. CH Wakefield PD Carey S Foulds 1993 Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery Br. J. Surg. 80 205
61. ML Steinhausen CM Hogaboam N Lukacs 1999 Multiple roles for IL-12 in a model of acute septic peritonitis J Immunol. 162 543
62. DA Zisman SL Kunkel RM Strieter 1997 Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs clearance in murine Escherichia coli peritoneal sepsis Shock 8 349
63. VB Fiedler I Loof E Sander 1992 Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys J. Lab. Clin. Med. 120 574
64. S Ikuta S Ono M Kinoshita 2003 Interleukin-18 concentration in the peritoneal fluid correlates severity of peritonitis Am. J. Surg. 185 550
65. C Wunder O Eichelbronner N Roewer 2004 Are IL-6, IL-10 and PCT plasma concentrations reliable for prediction in severe sepsis? A comparison with APACHE II SAPS II Inflamm. Res. 53 158
66. JB Seidelin CH Nielsen J Strom 2002 Soluble L-selectin levels predict survival in sepsis Intensive Care Med. 28 1613
67. S Beer H Weighardt K Emmanuilidis 2002 Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis Crit. Care Med. 30 1794
68. B Resch W Gusenleitner WD Muller 2003 Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate Acta. Paediatr. 92 243
69. T Calandra J Bernhagen RA Mitchell 1994 The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor J. Exp. Med. 79 1895
70. J Bernhagen T Calandra RA Mitchell 1993 MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia Nature. 65 756
71. NC Riedemann RF Guo PA Ward 2003 Novel strategies for the treatment of sepsis Nat. Med. 9 517
72. T Calandra B Echtenacher DL Roy 2000 Protection from septic shock by neutralization of macrophage migration inhibitory factor, Nat Med. 6 164
73. T Calandra L Spiegel CN Metz 1998 Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria Proc. Natl. Acad. Sci. J. U.S.A. 95 11383
74. SE Buijk HA Bruining 2004 Futire directions in the management of tertiary peritonitis Intensive Care Med. 28 1024
75. L Ulloa M Ochani H Yang 2002 Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Proc. Natl. Acad. Sci. U.S.A. 99 12351
76. C Fiuza M Bustin S Talwar 2003 Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2652
77. HS Shin R Snyderman E Friedman 1968 Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement Science 162 361
78. M Goldstein G Weissmann 1974 Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes J. Immunol. 113 1583
79. WA Schumacher JC Fantone SE Kunkel 1991 The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo Agents Actions 34 345
80. RF Quo M Huber-Lang X Wang 2000 Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis J. Clin. Invest. 106 1271
81. NC Riedemann RF Guo IJ Laudes 2002 C5a receptor and thymocyte apoptosis in sepsis F.A.S.E.B. J. 16 887
82. M Huber-Lang VJ Sarma KT Lu 2001 Role of C5a in multiorgan failure during sepsis J. Immunol. 66 1193
83. BJ Czermak V Sarma CL Pierson 1999 Protective effects of C5a blockade in sepsis, Nat Med. 5 788
84. NC Riedemann RF Guo TA Neff 2002 Increased C5a receptor expression in sepsis J. Clin. Invest. 110 101
85. NC Riedemann TA Neff RF Guo 2003 Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression J. Immunol. 170 503
86. RS Hotchkiss KW Tinsley PE Swanson 2001 Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans J. Immunol. 66 6952
87. H Wang O Bloom M Zhang 1999 HMG-1 as a late mediator of endotoxin lethality in mice Science 285 248
88. RS Hotchkiss PE Swanson CM Knudson 1999 Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis J. Immunol. 162 4148
89. B Beutler 2002 Toll-like receptors: how they work and what they do Curr. Opin. Hematol. 9 2
90. K Takeda T Kaisho S Akira 2003 Toll-like receptors Annu. Rev. Immunol. 21 335
91. CA Janeway R Medzhitov 2002 Innate immune recognition, Annu Rev. Immunol. 20 197
92. S Akira 2003 Toll-like receptor signaling J. Biol. Chem. 78 38105
93. H Weighardt S Kaiser-Moore RM Vabulas 2002 Myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection J. Immunol. 69 2823